Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation
Stopped No subjects have been accrued to this trial. The PI will no longer be at COH and requests a study withdrawal/closure.
Conditions
- Stage IIIA Non-small Cell Lung Cancer
Interventions
- PROCEDURE: positron emission tomography/computed tomography (PET/CT)
- RADIATION: fludeoxyglucose F 18
Sponsor
City of Hope Medical Center
Collaborators